Four subclones with distinct immunoglobulin light chain phenotypes. (kappa+lambda+, kappa+, lambda+ and...

Area of Science:

• Immunology
• Cell Biology
• Hematology

Background:

• Acute lymphoblastic leukemia (ALL) is a heterogeneous hematologic malignancy.
• B cell maturation involves complex immunoglobulin (Ig) expression.
• Simultaneous expression of kappa and lambda light chains is a rare phenomenon in B cells.

Purpose of the Study:

• To establish and characterize a novel human ALL cell line, BALM-9.
• To investigate the mechanism of simultaneous kappa and lambda light chain expression.
• To develop a model system for studying B cell maturation stages.

Main Methods:

• Establishment of the BALM-9 cell line from peripheral blood.
• Two-color flow cytometry for immunophenotyping.
• Limiting dilution for subclone isolation.
• Western blotting for protein analysis.
• Cytogenetic and Southern blotting for genetic analysis.

Main Results:

• BALM-9 cells exhibited a mixed immunoglobin (Ig) phenotype with kappa and lambda light chain expression.
• Distinct subclones (BALM-9KL, BALM-9K, BALM-9N) were isolated, representing different light chain expression patterns.
• Cytogenetic and Southern blotting confirmed shared ancestry and a common 14q32 chromosomal rearrangement.

Conclusions:

• The BALM-9 cell line and its subclones offer a valuable model for studying B cell development.
• The findings suggest that kappa lambda double positive B cells may represent a transient stage in normal B cell maturation.
• This model can aid in understanding the mechanisms underlying double light chain expression.